Eprotirome is a

thyromimetic Thyromimetic drugs are synthetic agonists of the thyroid hormone receptor's isoforms TR α1, TRα2, TRβ1, or TRβ2, mimicking some or all of the effects of endogenously produced thyroid hormones that regulate metabolism. Some thyromimetic drugs ar ...

drug that has been investigated for the treatment of

dyslipidemia Dyslipidemia is a metabolic disorder characterized by abnormally high or low amounts of any or all lipids (e.g. fats, triglycerides, cholesterol, phospholipids) or lipoproteins in the blood. Dyslipidemia is a risk factor for the development of ...

. A Phase III trial in humans was discontinued after the drug was found to have negative effects on

cartilage Cartilage is a resilient and smooth type of connective tissue. Semi-transparent and non-porous, it is usually covered by a tough and fibrous membrane called perichondrium. In tetrapods, it covers and protects the ends of long bones at the joints ...

in dogs.

References

{{reflist Thyroid hormone receptor beta agonists Abandoned drugs Carboxylic acids Bromobenzene derivatives Anilides Isopropyl compounds Phenols